Humana’s (HUM) Path to Recovery and Growth

3 weeks ago 7

Soumya Eswaran

Tue, August 4, 2026 astatine 11:04 AM CDT 3 min read

Hotchkis & Wiley, an concern absorption company, released its second-quarter 2026 capitalist missive for the "Hotchkis & Wiley Mid-Cap Value Fund." A transcript of the missive tin beryllium downloaded here. Equity markets posted beardown returns successful the 2nd 4th of 2026, with the Russell Midcap Index rising 13.8% and the Russell Midcap Value Index returning 13.4%, contempt concerns astir inflation, a hawkish Federal Reserve, and rising lipid prices owed to the Iran conflict. Narrow marketplace enactment was evident, peculiarly semiconductor stocks and different stocks successful the AI sector, which saw returns exceeding 100%. The Firm favors prime businesses with charismatic valuations, believing that fears regarding AI's interaction are overstated. The Hotchkis & Wiley Mid-Cap Value Fund lagged the Russell Midcap Value Index, achieving a 4.74% instrumentality successful the 2nd quarter, chiefly owed to underperformance successful exertion and vigor sectors, portion banal enactment successful healthcare contributed positively. In addition, delight cheque the Fund's apical 5 holdings to cognize its champion picks successful 2026.

In its Q2 2026 capitalist letter, Hotchkis & Wiley Mid-Cap Value Fund highlighted Humana Inc. (NYSE:HUM). Humana Inc. (NYSE:HUM), an American security institution that provides aesculapian and specialty security products, delivered beardown show during the quarter. On August 03, 2026, Humana Inc. (NYSE:HUM) closed astatine $374.50 per share. The one-month instrumentality of Humana Inc. (NYSE:HUM) was -5.10%, and its shares gained 47.17% implicit the past 52 weeks. Humana Inc. (NYSE:HUM) has a marketplace capitalization of $44.97 billion.

Hotchkis & Wiley Mid-Cap Value Fund stated the following regarding Humana Inc. (NYSE:HUM) successful its Q2 2026 capitalist letter:

"Humana Inc. (NYSE:HUM) is 1 of the largest axenic Medicare Advantage (MA) wellness insurer successful the United States. Performance implicit the 4th was beardown pursuing quality that the US agreed to summation 2027 payments for backstage MA plans supra its archetypal connection earlier successful the year. The company's banal has been undervalued owed to higher utilization by enrollees and uncertainty regarding reimbursement rates. We presumption these issues arsenic impermanent due to the fact that the institution reprices its concern each year, which could pb to a betterment successful margins."

JPMorgan and Mizuho Raise Humana (HUM) Price Targets arsenic Managed Care Outlook Improves

Humana Inc. (NYSE:HUM) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 61 hedge money portfolios held Humana Inc. (NYSE:HUM) astatine the extremity of the archetypal quarter, up from 53 successful the erstwhile quarter. While we admit the imaginable of Humana Inc. (NYSE:HUM) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article